KR930019203A - 메지스트롤 아세테이트 제제 - Google Patents
메지스트롤 아세테이트 제제 Download PDFInfo
- Publication number
- KR930019203A KR930019203A KR1019920010328A KR920010328A KR930019203A KR 930019203 A KR930019203 A KR 930019203A KR 1019920010328 A KR1019920010328 A KR 1019920010328A KR 920010328 A KR920010328 A KR 920010328A KR 930019203 A KR930019203 A KR 930019203A
- Authority
- KR
- South Korea
- Prior art keywords
- formulation
- concentration
- megestrol acetate
- weight
- polysorbate
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title claims abstract 10
- 239000000203 mixture Substances 0.000 title claims abstract 10
- 229960004296 megestrol acetate Drugs 0.000 title claims abstract 6
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 title claims abstract 6
- 239000000796 flavoring agent Substances 0.000 claims abstract 3
- 229920000136 polysorbate Polymers 0.000 claims abstract 3
- 229950008882 polysorbate Drugs 0.000 claims abstract 3
- 239000000872 buffer Substances 0.000 claims abstract 2
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract 2
- 235000003599 food sweetener Nutrition 0.000 claims abstract 2
- 239000003765 sweetening agent Substances 0.000 claims abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 229940068968 polysorbate 80 Drugs 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 238000005202 decontamination Methods 0.000 claims 1
- 230000003588 decontaminative effect Effects 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 235000019223 lemon-lime Nutrition 0.000 claims 1
- 239000008183 oral pharmaceutical preparation Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940100474 polyethylene glycol 1450 Drugs 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 235000010234 sodium benzoate Nutrition 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Manufacture, Treatment Of Glass Fibers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
본 발명은 안정한 서상화된 현탄액을 물에서 형성시키는 0.005 내지 0.015중량%/용적 농도의 폴리소르베이트및 5 내지 30%/용적 농도의 폴리에틸렌리콜을 함유하는 15내지 150㎎/㎖ 농도의 미분화된 메지스트롤 아세테이트의 신규한 경구용 약제학적 조성물에 관한 것이다. 본 발명은 또한 방부제, 완충제, 감미제 및 향미제를 가한 상기에서 기재한 미분화된 메지스트를 아세테이트 제제에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
15 내지 150㎎/㎖농도의 미분환된 메지스트롤 아세테이트를, 0.005내지 0.015중량%/용적농도의 폴리소르베이트 및 5중량%/용적이상 농도의 폴리에틸렌글리콜과 배합된 상태로 함유하며 안정한 서상화된 현탁제를 물중에서 형성시키는 경구용 약제학적 제제.
제1항에 있어서, 미분화된 메지스트롤 아세테이트의 농도가 20내지 120㎎.㎖인 제제.
제1항에 있어서, 미분화된 메지스트롤 아세테이트의 농도가 40㎎/㎖인 제제.
제1항에 있어서, 폴리소르베이트 80이 사용되는 제제.
제1항에 있어서, 폴리에틸렌글리콜의 농도가 5% 내지 30중량%/용적인 제제.
제1항에 있어서, 폴리에틸렌글리콜의 농도가 12 내지 24중량%/용적인 제제.
제1항에 있어서, 폴리에틸렌글리콜의 농도가 20중량%/용적인 제제.
제1항에 있어서, 폴리소르베이트이 농도가 0.01중량%/용적인 제제.
제1항에 있어서, 완충제, 감미제 및 향미제르리 사용하는 제제.
중량%/용적을 기준으로 하여 4%의 메지스트롤 아세테이트, 20%의 폴리에틸렌글리콜 1450, 0.01%의 폴리소르베이트80, 0.2%의 크산탄검, 0.2%의 벤조산나트륨, 0.244%의 구연산, 0.15%의 구연산나트륨, 5%의 슈크로스, 0.091%의 레몬-라임 향미제 및 나머지 정제수로 이루어지며, 안정한 서상화된 현탁제를 물중에서 형성시키는 약제학적제제.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71715591A | 1991-06-18 | 1991-06-18 | |
| US7/717,155 | 1991-06-18 | ||
| US07/717,155 | 1991-06-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR930019203A true KR930019203A (ko) | 1993-10-18 |
| KR100211192B1 KR100211192B1 (ko) | 1999-07-15 |
Family
ID=24880926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920010328A KR100211192B1 (ko) | 1991-06-18 | 1992-06-15 | 메지스트롤 아세테이트 제제 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5338732A (ko) |
| EP (1) | EP0519351B1 (ko) |
| JP (1) | JP3450356B2 (ko) |
| KR (1) | KR100211192B1 (ko) |
| CN (1) | CN1038904C (ko) |
| AT (1) | ATE142882T1 (ko) |
| AU (1) | AU647933B2 (ko) |
| CA (1) | CA2071141A1 (ko) |
| CZ (1) | CZ289620B6 (ko) |
| DE (1) | DE69213836T2 (ko) |
| DK (1) | DK0519351T3 (ko) |
| ES (1) | ES2091977T3 (ko) |
| FI (1) | FI101602B (ko) |
| GR (1) | GR3021072T3 (ko) |
| HK (1) | HK1005017A1 (ko) |
| HU (1) | HU213511B (ko) |
| IE (1) | IE77167B1 (ko) |
| IL (1) | IL102198A (ko) |
| MX (1) | MX9202944A (ko) |
| SK (1) | SK281841B6 (ko) |
| TW (1) | TW211520B (ko) |
| ZA (1) | ZA924282B (ko) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698562A (en) * | 1991-10-08 | 1997-12-16 | Ascent Pediatrics, Inc. | Palatable trimethoprim oral solution |
| US5563177A (en) * | 1995-01-30 | 1996-10-08 | American Home Products Corporation | Taste masking guaifenesin containing liquids |
| US6268356B1 (en) | 1998-04-20 | 2001-07-31 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6028065A (en) * | 1998-04-20 | 2000-02-22 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6656505B2 (en) * | 2000-07-21 | 2003-12-02 | Alpharma Uspd Inc. | Method for forming an aqueous flocculated suspension |
| US20030198679A1 (en) * | 2000-11-08 | 2003-10-23 | Kundu Subhas C. | Flocculated pharmaceutical suspensions and methods for actives |
| DK1275377T3 (da) * | 2001-07-11 | 2003-10-06 | Applied Pharma Res | Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf |
| US9101540B2 (en) | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
| US20100226989A1 (en) * | 2002-04-12 | 2010-09-09 | Elan Pharma International, Limited | Nanoparticulate megestrol formulations |
| EP2263650A3 (en) * | 2002-04-12 | 2013-12-25 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
| US20040105889A1 (en) * | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
| US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
| DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| KR100841082B1 (ko) | 2006-08-23 | 2008-06-24 | 대원제약주식회사 | 메게스트롤 아세테이트의 서상화된 현탁제 |
| KR20080035374A (ko) * | 2006-10-19 | 2008-04-23 | 주식회사 엘지생명과학 | 약제학적으로 안정한 메게스트롤 물질의 현탁액제 |
| CN101678112B (zh) * | 2007-01-19 | 2016-08-31 | 哈南亚有限公司 | 用于递送治疗剂的方法和组合物 |
| US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
| WO2008089549A1 (en) | 2007-01-22 | 2008-07-31 | Genpharm Ulc | Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| TW201023912A (en) * | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
| US8912236B2 (en) | 2009-03-03 | 2014-12-16 | Alcon Research, Ltd. | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| KR101279568B1 (ko) * | 2010-12-10 | 2013-07-15 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | 메게스트롤 아세테이트를 포함하는 경구용 약학 조성물 |
| CN113274351B (zh) * | 2020-02-20 | 2024-04-12 | 东曜药业有限公司 | 一种口服醋酸甲地孕酮混悬液及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB870286A (en) * | 1958-11-04 | 1961-06-14 | British Drug Houses Ltd | Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds |
| FR2290906A1 (fr) * | 1974-11-13 | 1976-06-11 | Dick Pierre | Nouvelles associations hormonales synergisees pour l'implantation d'animaux de boucherie |
| US4370321A (en) * | 1976-09-01 | 1983-01-25 | Mead Johnson And Company | Progestational adjuvant therapy |
| JPS5522631A (en) * | 1978-08-07 | 1980-02-18 | Ota Seiyaku Kk | Readily absorbable nifedipine preparation |
| US4402695A (en) * | 1980-01-21 | 1983-09-06 | Alza Corporation | Device for delivering agent in vagina |
| US4396615A (en) * | 1981-06-24 | 1983-08-02 | Duke University | Method of treating androgen-related disorders |
| US4760053A (en) * | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
| US4666885A (en) * | 1985-02-08 | 1987-05-19 | Fernand Labrie | Combination therapy for treatment of female breast cancer |
| US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
-
1992
- 1992-05-13 US US07/882,218 patent/US5338732A/en not_active Expired - Lifetime
- 1992-06-11 ZA ZA924282A patent/ZA924282B/xx unknown
- 1992-06-12 AT AT92109946T patent/ATE142882T1/de not_active IP Right Cessation
- 1992-06-12 EP EP92109946A patent/EP0519351B1/en not_active Expired - Lifetime
- 1992-06-12 ES ES92109946T patent/ES2091977T3/es not_active Expired - Lifetime
- 1992-06-12 TW TW081104618A patent/TW211520B/zh not_active IP Right Cessation
- 1992-06-12 DK DK92109946.1T patent/DK0519351T3/da active
- 1992-06-12 DE DE69213836T patent/DE69213836T2/de not_active Expired - Fee Related
- 1992-06-12 CA CA002071141A patent/CA2071141A1/en not_active Abandoned
- 1992-06-15 IL IL10219892A patent/IL102198A/en not_active IP Right Cessation
- 1992-06-15 FI FI922764A patent/FI101602B/fi active
- 1992-06-15 KR KR1019920010328A patent/KR100211192B1/ko not_active IP Right Cessation
- 1992-06-16 CZ CS19921853A patent/CZ289620B6/cs not_active IP Right Cessation
- 1992-06-16 SK SK1853-92A patent/SK281841B6/sk not_active IP Right Cessation
- 1992-06-17 CN CN92104762A patent/CN1038904C/zh not_active Expired - Fee Related
- 1992-06-17 MX MX9202944A patent/MX9202944A/es unknown
- 1992-06-17 AU AU18281/92A patent/AU647933B2/en not_active Expired
- 1992-06-17 JP JP19889292A patent/JP3450356B2/ja not_active Expired - Lifetime
- 1992-06-17 HU HU9202029A patent/HU213511B/hu unknown
- 1992-07-01 IE IE921958A patent/IE77167B1/en not_active IP Right Cessation
-
1996
- 1996-09-19 GR GR960400478T patent/GR3021072T3/el unknown
-
1998
- 1998-05-15 HK HK98104209A patent/HK1005017A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930019203A (ko) | 메지스트롤 아세테이트 제제 | |
| KR900013952A (ko) | 경구투여용 이부프로펜 조성물 | |
| KR890001532A (ko) | 소아용 이부프로펜제제 및 그의 제조방법 | |
| BR9302738A (pt) | Composicao oral substancialmente nao irritante,com sabor aceitavel | |
| IT1178235B (it) | Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione | |
| KR950701224A (ko) | 경구 현탁액 제형을 위한 안정한 수화 세팔로스포린 건조 분말(Stable hydrated cephalosporin dry powder for aral suspension formulation) | |
| AU5453894A (en) | Antibacterial mouthwash | |
| KR950703327A (ko) | 씹을 수 있는 라니티딘 정제(Ranitidine Chewable Tablets) | |
| KR880007060A (ko) | 제약 조성물 | |
| ATE65395T1 (de) | Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel. | |
| US3526698A (en) | Stabilization of levo-3-(3,4-dihydroxyphenyl)-2-methylalanine with sodium bisulfite and sorbitol | |
| EP0011868A1 (en) | Methyldopa composition | |
| GB1293048A (en) | Flavour composition | |
| TH20307A (th) | สารสูตรผสมอิมัลชันชนิดใหม่ | |
| TH20307EX (th) | สารสูตรผสมอิมัลชันชนิดใหม่ | |
| KR890016962A (ko) | 경구용 해열진통제 액상의 제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20090424 Year of fee payment: 11 |
|
| LAPS | Lapse due to unpaid annual fee |